Hostname: page-component-78c5997874-ndw9j Total loading time: 0 Render date: 2024-11-04T19:13:53.029Z Has data issue: false hasContentIssue false

Gene therapy: potential applications in clinical transplantation

Published online by Cambridge University Press:  11 February 2004

Kathryn J. Wood
Affiliation:
Nuffield Department of Surgery, University of Oxford, The John Radcliffe Hospital, Headington, Oxford, OX3 9DU, UK.
Jeremy Fry
Affiliation:
Nuffield Department of Surgery, University of Oxford, The John Radcliffe Hospital, Headington, Oxford, OX3 9DU, UK.

Abstract

Gene therapy continues to offer much hope for the future treatment of a variety of clinical conditions. The development of tailored, novel gene transfer vectors will improve the efficiency and stability of therapeutic gene expression in the many settings of gene therapy. In the context of tissue and organ transplantation, gene therapy is being harnessed to prevent the acute and chronic rejection of transplanted tissues by introducing either new genes that are important in preventing rejection (e.g. co-stimulatory blocking molecules or immunosuppressive cytokines) or antisense nucleic acids to block the production of rejection-associated molecules such as adhesion molecules. The delivery of genes by gene therapy vectors that encode foreign donor antigens (alloantigens) might also be an effective means of inducing donor-specific unresponsiveness (immunological tolerance) in the recipient, perhaps eliminating the requirement for potentially harmful whole-body immunosuppression.

Type
Review Article
Copyright
© Cambridge University Press 1999

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)